Pharmacologic considerations in the neonate with congenital heart disease

Clinics in Perinatology

Volumn 28, Issue 1, 2001, Pages 209-222

  Calligaro, Ina Lee ^a   Burman, Cynthia A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMIODARONE; AMRINONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ENALAPRIL; ENALAPRILAT; FLECAINIDE; MILRINONE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE INHIBITOR; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL;

ACUTE KIDNEY FAILURE; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; DIARRHEA; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERABILITY; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; LETHARGY; NEWBORN; OLIGURIA; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

EID: 0035101329     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-5108(05)70075-0     Document Type: Article

References (46)

1. Age-related amrinone pharmacokinetics in a pediatric population
2. A comparison of the hemodynamic effects of amrinone and sodium nitroprusside in infants after cardiac surgery
3. Arrhythmias
4. Higher adenosine dosage required for supraventricular tachycardia in infants treated with theophylline
5. Improved cardiac performance with amrinone in pediatric patients with cardiomyopathy
6. Therapeutic monitoring and pharmacokinetic evaluation of procainamide in neonates
7. Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts
8. Milrinone: Systemic and pulmonary hemodynamic effects in neonates after cardiac surgery
9. Consensus recommendations for the management of chronic heart failure
10. Acute pulmonary toxicity in an infant from intravenous amiodarone
11. Clinical recognition and management of chronic congestive cardiac failure
12. Management of acute congestive heart failure
13. Enalapril for severe heart failure in infancy
14. Intraosseous adenosine: As effective as peripheral or central venous administration?
15. Intravenous and oral propafenone for treatment of tachycardia in infants and children: Pharmacokinetics and clinical response
16. Heart failure
17. Amrinone in neonates and infants after cardiac surgery
18. Efficacy and dosage of enalapril in congenital and acquired heart disease
19. Pharmacokinetic and pharmacodynamics of milrinone lactate in pediatric patients with septic shock
20. Orally administered enalapril for infants with congestive heart failure: A dose-finding study
21. Antiarrhythmic drugs
22. Supraventricular tachycardia
23. Captopril in infants for congestive heart failure secondary to a large ventricular left-to-right shunt
24. The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure
25. Digoxin and flecainide for prophylaxis of supraventricular tachycardia in infants?
26. The pharmacokinetics of captopril in infants with congestive heart failure
27. Flecainide acetate for treatment of tachyarrhythmias in children: Review of world literature on efficacy, safety, and dosing
28. Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery
29. Acute hemodynamic effects of converting enzyme inhibition in infants with congestive heart failure
30. Selective pulmonary and systemic vasodilator effects of amrinone in children: New therapeutic implications
31. Amrinone-associated thrombocytopenia: Pharmacokinetic analysis
32. Captopril in treatment of infant heart failure: A preliminary report
33. Cardiovascular, renal, and endocrine actions of dopamine in neonates and children
34. Regional hemodynamic effects of dopamine in the sick preterm neonate
35. Short-term hemodynamic effects of captopril in infants with congestive heart failure
36. Captopril in heart failure secondary to a left to right shunt
37. Intravenous enalaprilat and oral enalapril in congestive heart failure secondary to ventricular septal defect in infancy
38. Captopril in children with dilated cardiomyopathy: Acute and long-term effects in a prospective study of hemodynamic and hormonal effects
39. Supraventricular tachycardia: Diagnosis and current acute management
40. Dopamine suppresses pituitary function in infants and children
41. Safety of amrinone for treating congestive heart failure in a premature neonate
42. Efficacy and risks of medical therapy for supraventricular tachycardia in neonates and infants
43. Use of catecholamines in pediatrics